Vaccine safety and efficacy evaluation of a recombinant Bovine Respiratory Syncytial Virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Blodörn, Krister ^a   Hägglund, Sara ^a   Fix, Jenna ^b   Dubuquoy, Catherine ^b   Makabi Panzu, Boby ^c   Thom, Michelle ^c   Karlsson, Per ^d   Roque, Jean Louis ^e   Karlstam, Erika ^d   Pringle, John ^a   Eléouët, Jean François ^b   Riffault, Sabine ^b   Taylor, Geraldine ^c   Valarcher, Jean François ^a,d  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b INRA Institut National de la Recherche Agronomique   (France)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^d NATIONAL VETERINARY INSTITUTE   (Sweden)

^e CLINIQUE VÉTÉRINAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN A; IMMUNOLOGICAL ADJUVANT; IMMUNOSTIMULATING AGENT; MATERNAL ANTIBODY; MONTANIDE ISA 71; NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; SUBUNIT VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BOVINE RESPIRATORY SYNCYTIAL VIRUS INFECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; GENE DELETION; IMMUNIZATION; IMMUNOSTIMULATION; NONHUMAN; PROTEIN SUBUNIT; SEROLOGY; VIRUS IMMUNITY; VIRUS RECOMBINANT; VIRUS SHEDDING; VIRUS VIRULENCE; AMINO ACID SEQUENCE; ANIMAL; BLOOD; BOVINE; BOVINE RESPIRATORY SYNCYTIAL VIRUS; CHEMISTRY; GENETICS; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; LUNG; LYMPH NODE; LYMPHOCYTE; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PATHOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SPECIES DIFFERENCE; VACCINATION; VIROLOGY; VIRULENCE; VIRUS GENE; VIRUS LOAD;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CATTLE; EPITOPES; GENE DELETION; GENES, VIRAL; HUMANS; LUNG; LYMPH NODES; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SPECIES SPECIFICITY; VACCINATION; VACCINES, SUBUNIT; VIRAL LOAD; VIRAL PROTEINS; VIRULENCE;

EID: 84903388396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100392     Document Type: Article

References (66)

1. Valarcher J-F, Taylor G (2007) Bovine respiratory syncytial virus infection. Vet Res 38: 153-180. doi:10.1051/vetres:2006053.
2. Seiffert SN, Hilty M, Perreten V, Endimiani A (2013) Extended-spectrum cephalosporin-resistant gram-negative organisms in livestock: An emerging problem for human health? Drug Resist Updat. doi:10.1016/j.drup.2012.12.001.
3. Fulton RW (2009) Bovine respiratory disease research (1983-2009). Anim Health Res Rev 10: 131-139. doi:10.1017/S146625230999017X.
4. Kimman TG, Zimmer GM, Westenbrink F, Mars J, van Leeuwen E (1988) Epidemiological study of bovine respiratory syncytial virus infections in calves: influence of maternal antibodies on the outcome of disease. Vet Rec 123: 104-109.
5. Kimman TG, Westenbrink F, Straver PJ (1989) Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies. Vet Immunol Immunopathol 22: 145-160.
6. Chase CCL, Hurley DJ, Reber AJ (2008) Neonatal immune development in the calf and its impact on vaccine response. Vet Clin North Am Food Anim Pract 24: 87-104. doi:10.1016/j.cvfa.2007.11.001.
7. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545-1555. doi:10.1016/S0140-6736(10)60206-1.
8. Westenbrink F, Kimman TG, Brinkhof JM (1989) Analysis of the antibody response to bovine respiratory syncytial virus proteins in calves. J Gen Virol 70 (Pt 3): 591-601.
9. Walsh EE, Hall CB, Briselli M, Brandriss MW, Schlesinger JJ (1987) Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J Infect Dis 155: 1198-1204.
10. Taylor G, Thomas LH, Furze JM, Cook RS, Wyld SG, et al. (1997) Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions. J Gen Virol 78 (Pt 12): 3195-3206.
11. Taylor G, Bruce C, Barbet AF, Wyld SG, Thomas LH (2005) DNA vaccination against respiratory syncytial virus in young calves. Vaccine 23: 1242-1250. doi:10.1016/j.vaccine.2004.09.005.
12. Hägglund S, Hu K, Vargmar K, Poré L, Olofson A-S, et al. (2011) Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves. Vaccine 29: 8719-8730. doi:10.1016/j.vaccine. 2011.07.146.
13. Kimman TG, Westenbrink F, Schreuder BE, Straver PJ (1987) Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies. J Clin Microbiol 25: 1097-1106.
14. Gaddum RM, Cook RS, Furze JM, Ellis SA, Taylor G (2003) Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes. Immunology 108: 220-229.
15. Taylor G, Thomas LH, Wyld SG, Furze J, Sopp P, et al. (1995) Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J Virol 69: 6658-6664.
16. Rudraraju R, Jones BG, Sealy R, Surman SL, Hurwitz JL (2013) Respiratory syncytial virus: current progress in vaccine development. Viruses 5: 577-594. doi:10.3390/v5020577.
17. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, et al. (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89: 422-434.
18. Ellis J, Gow S, West K, Waldner C, Rhodes C, et al. (2007) Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration. J Am Vet Med Assoc 230: 233-243. doi:10.2460/javma.230.2.233.
19. Kimman TG, Sol J, Westenbrink F, Straver PJ (1989) A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine. Vet Q 11: 250-253. doi:10.1080/01652176.1989.9694231.
20. Schreiber P, Matheise JP, Dessy F, Heimann M, Letesson JJ, et al. (2000) High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine. J Vet Med B Infect Dis Vet Public Health 47: 535-550.
21. Antonis AFG, Schrijver RS, Daus F, Steverink PJGM, Stockhofe N, et al. (2003) Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis. J Virol 77: 12067-12073.
22. Meyer G, Deplanche M, Schelcher F (2008) Human and bovine respiratory syncytial virus vaccine research and development. Comp Immunol Microbiol Infect Dis 31: 191-225. doi:10.1016/j.cimid.2007.07.008.
23. Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, et al. (2005) Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis 191: 1093-1104. doi:10.1086/427813.
24. Taylor G, Wyld S, Valarcher J-F, Guzman E, Thom M, et al. (2014) Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves. J Gen Virol. doi:10.1099/vir.0.064931-0.
25. Riffault S, Meyer G, Deplanche M, Dubuquoy C, Durand G, et al. (2010) A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus. Vaccine 28: 3722-3734. doi:10.1016/j.vaccine.2010.03.008.
26. Stott EJ, Thomas LH, Collins AP, Crouch S, Jebbett J, et al. (1980) A survey of virus infections of the respiratory tract of cattle and their association with disease. J Hyg (Lond) 85: 257-270.
27. Mohanty SB, Ingling AL, Lillie MG (1975) Experimentally induced respiratory syncytial viral infection in calves. Am J Vet Res 36: 417-419.
28. Karger A, Schmidt U, Buchholz UJ (2001) Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin. J Gen Virol 82: 631-640.
29. Valarcher J-F, Furze J, Wyld S, Cook R, Conzelmann K-K, et al. (2003) Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol 77: 8426-8439.
30. Thomas LH, Gourlay RN, Stott EJ, Howard CJ, Bridger JC (1982) A search for new microorganisms in calf pneumonia by the inoculation of gnotobiotic calves. Res Vet Sci 33: 170-182.
31. Tran T-L, Castagné N, Dubosclard V, Noinville S, Koch E, et al. (2009) The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner. J Virol 83: 6363-6374. doi:10.1128/JVI.00335-09.
32. Tran T-L, Castagné N, Bhella D, Varela PF, Bernard J, et al. (2007) The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer. J Gen Virol 88: 196-206. doi:10.1099/vir.0.82282-0.
33. Castagné N, Barbier A, Bernard J, Rezaei H, Huet J-C, et al. (2004) Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain. J Gen Virol 85: 1643-1653.
34. Roux X, Dubuquoy C, Durand G, Tran-Tolla T-L, Castagné N, et al. (2008) Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus. PLoS ONE 3: e1766. doi:10.1371/journal.pone.0001766.
35. Tawar RG, Duquerroy S, Vonrhein C, Varela PF, Damier-Piolle L, et al. (2009) Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science 326: 1279-1283. doi:10.1126/science. 1177634.
36. Larsen LE, Uttenthal A, Arctander P, Tjørnehøj K, Viuff B, et al. (1998) Serological and genetic characterisation of bovine respiratory syncytial virus (BRSV) indicates that Danish isolates belong to the intermediate subgroup: no evidence of a selective effect on the variability of G protein nucleotide sequence by prior cell culture adaption and passages in cell culture or calves. Vet Microbiol 62: 265-279.
37. Chargelegue D, Obeid OE, Hsu SC, Shaw MD, Denbury AN, et al. (1998) A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo. J Virol 72: 2040-2046.
38. Arbiza J, Taylor G, López JA, Furze J, Wyld S, et al. (1992) Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol 73 (Pt 9): 2225-2234.
39. Furze JM, Roberts SR, Wertz GW, Taylor G (1997) Antigenically distinct G glycoproteins of BRSV strains share a high degree of genetic homogeneity. Virology 231: 48-58. doi:10.1006/viro.1997.8490.
40. McLellan JS, Yang Y, Graham BS, Kwong PD (2011) Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J Virol 85: 7788-7796. doi:10.1128/JVI.00555-11.
41. Uttenthal A, Larsen LE, Philipsen JS, Tjørnehøj K, Viuff B, et al. (2000) Antibody dynamics in BRSV-infected Danish dairy herds as determined by isotype-specific immunoglobulins. Vet Microbiol 76: 329-341.
42. Kennedy HE, Jones BV, Tucker EM, Ford NJ, Clarke SW, et al. (1988) Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus. J Gen Virol 69 (Pt 12): 3023-3032.
43. Viuff B, Uttenthal A, Tegtmeier C, Alexandersen S (1996) Sites of replication of bovine respiratory syncytial virus in naturally infected calves as determined by in situ hybridization. Vet Pathol 33: 383-390.
44. Bryson D (1993) Necropsy findings associated with BRSV pneumonia. Vet Med 88: 894-899.
45. Belyakov IM, Ahlers JD (2009) What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J Immunol 183: 6883-6892. doi:10.4049/jimmunol.0901466.
46. Wu S-J, Schmidt A, Beil EJ, Day ND, Branigan PJ, et al. (2007) Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches. J Gen Virol 88: 2719-2723. doi:10.1099/vir.0.82753-0.
47. Thomas LH, Cook RS, Wyld SG, Furze JM, Taylor G (1998) Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus. J Infect Dis 177: 874-880.
48. Bastien N, Taylor G, Thomas LH, Wyld SG, Simard C, et al. (1997) Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host. Vaccine 15: 1385-1390.
49. Fogg MH, Parsons KR, Thomas LH, Taylor G (2001) Identification of CD4+ T cell epitopes on the fusion (F) and attachment (G) proteins of bovine respiratory syncytial virus (BRSV). Vaccine 19: 3226-3240.
50. Hervé P-L, Raliou M, Bourdieu C, Dubuquoy C, Petit-Camurdan A, et al. (2014) A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2. J Virol 88: 325-338. doi:10.1128/JVI.01141-13.
51. Samal SK, Zamora M, McPhillips TH, Mohanty SB (1991) Molecular cloning and sequence analysis of bovine respiratory syncytial virus mRNA encoding the major nucleocapsid protein. Virology 180: 453-456.
52. Mallipeddi SK, Samal SK (1992) Sequence comparison between the phosphoprotein mRNAs of human and bovine respiratory syncytial viruses identifies a divergent domain in the predicted protein. J Gen Virol 73 (Pt 9): 2441-2444.
53. Zamora M, Samal SK (1992) Sequence analysis of M2 mRNA of bovine respiratory syncytial virus obtained from an F-M2 dicistronic mRNA suggests structural homology with that of human respiratory syncytial virus. J Gen Virol 73 (Pt 3): 737-741.
54. Piazza FM, Johnson SA, Darnell ME, Porter DD, Hemming VG, et al. (1993) Bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection. J Virol 67: 1503-1510.
55. Buchholz UJ, Granzow H, Schuldt K, Whitehead SS, Murphy BR, et al. (2000) Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine. J Virol 74: 1187-1199.
56. Thomas LH, Stott EJ, Collins AP, Crouch S, Jebbett J (1984) Infection of gnotobiotic calves with a bovine and human isolate of respiratory syncytial virus. Modification of the response by dexamethasone. Arch Virol 79: 67-77.
57. McLellan JS, Chen M, Joyce MG, Sastry M, Stewart-Jones GBE, et al. (2013) Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342: 592-598. doi:10.1126/science.1243283.
58. Aucouturier J, Dupuis L, Ganne V (2001) Adjuvants designed for veterinary and human vaccines. Vaccine 19: 2666-2672.
59. Duewell P, Kisser U, Heckelsmiller K, Hoves S, Stoitzner P, et al. (2011) ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8+ T Cells. J Immunol. Available: http://www.ncbi.nlm.nih.gov/pubmed/21613613. Accessed 30 May 2011.
60. Robson NC, Donachie AM, Mowat AM (2008) Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells. Eur J Immunol 38: 1238-1246. doi:10.1002/eji. 200737758.
61. Schnurr M, Orban M, Robson NC, Shin A, Braley H, et al. (2009) ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II. J Immunol 182: 1253-1259.
62. Hägglund S, Hu K-F, Larsen LE, Hakhverdyan M, Valarcher J-F, et al. (2004) Bovine respiratory syncytial virus ISCOMs-protection in the presence of maternal antibodies. Vaccine 23: 646-655. doi:10.1016/j.vaccine.2004.07.006.
63. Hägglund S, Hu K, Blodörn K, Makabi-Panzu B, Gaillard A-L, et al. (2014) Characterization of an experimental vaccine for bovine respiratory syncytial virus. Clin Vaccine Immunol: CVI.00162-14. doi:10.1128/CVI.00162-14.
64. Ellis JA, Gow SP, Mahan S, Leyh R (2013) Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves. J Am Vet Med Assoc 243: 1602-1608. doi:10.2460/javma.243.11.1602.
65. Paton DJ, de Clercq K, Greiner M, Dekker A, Brocchi E, et al. (2006) Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine 24: 6503-6512. doi:10.1016/j.vaccine.2006.06.032.
66. Valarcher JF, Schelcher F, Bourhy H (2000) Evolution of bovine respiratory syncytial virus. J Virol 74: 10714-10728.